Michael Kenneth Draper

US Patent:

6841546, Jan 11, 2005

Filed:

Mar 14, 2002

Appl. No.:

10/097457

Inventors:

Michael Draper - Plaistow NH, US
Mark L. Nelson - Wellesley MA, US

Assignee:

Paratek Pharmaceuticals, Inc. - Boston MA

International Classification:

A61K 3165
A01N 3718

US Classification:

514152

Abstract:

Methods and compositions for treating fungal associated disorders in subjects are discussed.

US Patent:

7045507, May 16, 2006

Filed:

Mar 14, 2002

Appl. No.:

10/097634

Inventors:

Michael Draper - Plaistow NH, US
Mark L. Nelson - Wellesley MA, US

Assignee:

Paratek Pharmaceuticals, Inc. - Boston MA

International Classification:

A61K 31/70
A61K 31/65
A61K 31/415

US Classification:

514 31, 514152, 514394, 514395

Abstract:

Methods and compositions for treating for the synergistic treatment of fungal associated disorders are discussed.

US Patent:

7935687, May 3, 2011

Filed:

Apr 14, 2008

Appl. No.:

12/102623

Inventors:

Joel Berniac - Stoneham MA, US
Todd Bowser - Charlton MA, US
Michael Draper - Plaistow NH, US
Stuart B. Levy - Boston MA, US
Mark L. Nelson - Norfolk MA, US

Assignee:

Paratek Pharmaceuticals, Inc. - Boston MA

International Classification:

A61K 31/835
A61K 31/16

US Classification:

514152, 5142315, 514616

Abstract:

Methods for using tetracycline compounds for the treatment of spinal muscular atrophy are described.

US Patent:

7960366, Jun 14, 2011

Filed:

Sep 16, 2004

Appl. No.:

10/943571

Inventors:

Michael Draper - Plaistow NH, US
Mark L. Nelson - Norfolk MA, US

Assignee:

Paratek Pharmaceuticals, Inc. - Boston MA

International Classification:

A61K 31/65
A01N 37/18

US Classification:

514154

Abstract:

Methods and compositions for treating for the synergistic treatment of fungal associated disorders are discussed.

US Patent:

8088820, Jan 3, 2012

Filed:

Oct 24, 2003

Appl. No.:

10/692563

Inventors:

Michael Draper - Plaistow NH, US
Mark L. Nelson - Norfolk MA, US

Assignee:

Paratek Pharmaceuticals, Inc. - Boston MA

International Classification:

A61K 31/36
C07D 317/50
C07D 317/54
C07D 317/58

US Classification:

514464, 514441, 514452, 514466, 549443, 549444, 549446

Abstract:

This invention provides a method for treating or preventing malaria in a subject. The method includes administering to the subject an effective amount of a substituted tetracycline compound, such that malaria is treated or prevented. In one aspect, the invention relates to pharmaceutical compositions which include an effective amount of a tetracycline compound to treat malaria in a subject and a pharmaceutically acceptable carrier. The substituted tetracycline compounds of the invention can be used to in combination with one or more anti-malarial compounds or can be used to treat or prevent malaria which is resistant to one or more other anti-malarial compounds.

US Patent:

8399437, Mar 19, 2013

Filed:

May 3, 2011

Appl. No.:

13/099993

Inventors:

Joel Berniac - Stoneham MA, US
Todd Bowser - Charlton MA, US
Michael P. Draper - Windham NH, US
Stuart B. Levy - Boston MA, US
Mark L. Nelson - Norfolk MA, US

Assignee:

Paratek Pharmaceuticals, Inc. - Boston MA

International Classification:

A61K 31/835
A61K 31/16

US Classification:

514152, 5142315, 514616

Abstract:

Methods for using tetracycline compounds for the treatment of spinal muscular atrophy are described.

US Patent:

20040092490, May 13, 2004

Filed:

Apr 24, 2002

Appl. No.:

10/128990

Inventors:

Michael Draper - Plaistow NH, US
Mark Nelson - Wellesley MA, US

International Classification:

A61K031/65
A61K031/473
A61K031/353
A61K031/385

US Classification:

514/152000, 514/284000, 514/434000, 514/453000

Abstract:

This invention provides a method for treating or preventing malaria in a subject. The method includes administering to the subject an effective amount of a substituted tetracycline compound, such that malaria is treated or prevented. In one aspect, the invention relates to pharmaceutical compositions which include an effective amount of a tetracycline compound to treat malaria in a subject and a pharmaceutically acceptable carrier. The substituted tetracycline compounds of the invention can be used to in combination with one or more anti-malarial compounds or can be used to treat or prevent malaria which is resistant to one or more other anti-malarial compounds.

US Patent:

20050020545, Jan 27, 2005

Filed:

Aug 18, 2004

Appl. No.:

10/921580

Inventors:

Michael Draper - Plaistow NH, US
Mark Nelson - Norfolk MA, US

Assignee:

Paratek Pharmaceuticals, Inc. - Boston MA

International Classification:

A61K031/65

US Classification:

514152000

Abstract:

Methods and compositions for treating fungal associated disorders in subjects are discussed.